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The site-specific incorporation of non-natural amino acids
into proteins by nonsense suppression has been widely used
to investigate protein structure and function. Usually this
technique exhibits low incorporation efficiencies of non-
natural amino acids into proteins. We describe for the first
time an approach for achieving an increased level of non-
sense codon suppression with synthetic suppressor tRNAs
in cultured human cells. We find that the intracellular
concentration of the eukaryotic release factor 1 (eRF1) is
a critical parameter influencing the efficiency of amino
acid incorporation by nonsense suppression. Using RNA
interference we were able to lower eRF1 gene expression
significantly. We achieved a five times higher level of amino
acid incorporation as compared with non-treated control
cells, as demonstrated by enhanced green fluorescent
protein (EGFP) fluorescence recovery after importing a
mutated reporter mRNA together with an artificial amber
suppressor tRNA.
Keywords: eukaryotic release factor 1/fluorescent proteins/
gene silencing/protein design/suppressor tRNA
Introduction
The site-specific incorporation of non-natural amino acids into
proteins by nonsense suppression opens up novel routes for
protein engineering (Strømgaard et al., 2004). For example,
individual proteins can be site-selectively equipped with fluor-
escent, photo-activatable or other reactive probes suitable for
structural and functional investigations. Originally developed
as an in vitro labeling technique (Kurzchalia et al., 1988; Noren
et al., 1990; Cload et al., 1996; Karginov et al., 1997; Hohsaka
et al., 1998; Short et al., 1999), nonsense suppression has been
progressively adapted to prokaryotic (Liu et al., 1997; Liu and
Schultz, 1999; Wang et al., 2001, 2002) and eukaryotic cells
(Turcatti et al., 1996, 1997; Chollet et al., 1998; Beene et al.,
2002; Cohen et al., 2002). Recently, the scope of this technique
was expanded to mammalian live cells (Ilegems et al., 2002),
yielding suppression efficiencies of the order of 15% and allow-
ing the site-specific modification of proteins with non-natural
amino acids (Monahan et al., 2003). Here we report on
strategies to increase substantially the level of nonsense sup-
pression efficiency in cultured mammalian cells.
The intracellular concentration of the eukaryotic release
factor 1 (eRF1) is a parameter that is known to influence
natural nonsense suppression efficiency (Carnes et al., 2000).
Published data point to competitive actions between natural
suppressor tRNAs and eRF1 for stop codon recognition based
on their structural similarity and on their assumed common
binding site to the ribosome (Drugeon et al., 1997; Bertram
et al., 2000, 2001). Whereas a suppressor tRNA is required for
incorporation of amino acids and ribosomal read-through, the
eRF1 factor triggers the release of the nascent peptide resulting
in termination of translation (Carnes et al., 2000). Overexpres-
sion of eRF1 was shown to increase termination efficiency
(Le Goff et al., 1997) whereas a decreased eRF1 activity pro-
moted stop codon read-through in eukaryotic cells (Carnes
et al., 2000). Analogous findings were achieved in prokaryotic
cell-free translation systems using partially heat inactivated
S-30 extracts that express a temperature sensitive variant of
Escherichia coli release factor 1 (RF1) (Short et al., 1999).
Furthermore, it has been shown in recent studies that mRNAs
containing a premature stop codon spatially distant from the
30 end can be degraded by a Upf1 complex in which the eRF1 is
involved (Czaplinski et al., 1998; Hilleren and Parker, 1999).
These observations point to eRF1 as a factor which is poten-
tially influencing nonsense codon suppression also in presence
of artificial suppressor tRNAs.
Here we explore the feasibility of post-transcriptional gene
silencing of eRF1 to achieve higher efficiencies of amino acid
incorporation by nonsense suppression in HEK293 cells. The
silencing property of short interfering RNAs (Elbashir et al.,
2001a,b; Chiu and Rana, 2002; McManus and Sharp, 2002)
was used to target eRF1 messenger RNA. Changes in eRF1
gene expression were quantified by real-time RT-PCR. The
effects of eRF1 silencing on nonsense suppression efficiency
were investigated using an enhanced green fluorescent
protein (EGFP) reporter transcript carrying an amber codon
suppression site at an amino acid position, which is essential
for fluorophore formation, as described previously (Ilegems
et al., 2002). We found that only the co-injection of the mutated
EGFP reporter messenger RNA together with an artificial
suppressor tRNA, which can be aminoacylated in vivo, gave
rise to detectable EGFP fluorescence signals inside HEK293
cells indicating site-specific nonsense suppression events. The
level of EGFP fluorescence recovery reflected the suppression
efficiency and could be quantified in eRF1 silenced cells com-
pared with non-treated cells using laser-scanning confocal
microscopy.
Materials and methods
Materials
Synthetic oligonucleotides were purchased from MWG-
Biotech (Ebersberg, Germany), kits for plasmid and DNA
fragment purification from QIAGEN GmbH (Hilden,
Germany), restriction endonucleases (BsaI, EcoRI and NotI)
from New England Biolabs (Beverly, MA), MEGAscript and
MEGAshortscript kits for in vitro transcription and also the
cap analog m7G(50)ppp(50)G from Ambion (Austin, TX) and
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purified rEGFP from Clontech (Palo Alto, CA). All other
chemicals were obtained from Sigma-Aldrich (St. Louis, MO).
Cell culture
Adherent mammalian cells (Human Embryonic Kidney,
HEK293) were grown in DMEM/F12 (Dulbecco’s modified
Eagle medium; GIBCO BRL, Rockville, MD). The medium
was supplemented with 2.2% fetal calf serum (GIBCO BRL).
One day prior to injection, cells were transferred to 35/12 mm
WillCo-dishes (WPI, Stevenage, UK) at a density of
100 000 cells/ml and kept at 37C in a humidified atmosphere
with 5% CO2.
siRNA synthesis and transfection
The siRNA targeting the eRF1 mRNA was synthesized by
annealing in vitro transcripts as depicted in Figure 1A: for
each RNA fragment, two synthetic DNA oligonucleotides
were annealed to obtain templates flanked by a double-
stranded T7 promoter (Milligan et al., 1987). In vitro trans-
criptions were performed using the MEGAshortscript kit
(Ambion). After removing the DNA templates by DNaseI
treatment, the resulting RNAs were purified by successive
phenol–chloroform–isoamyl alcohol (25:24:1) and chloroform–
isoamyl alcohol (24:1) extractions. RNA precipitation was
achieved by adding an equal volume of isopropanol and by
incubation for 1 h at20C, followed by centrifugation at 0C/
20 800 g for 15 min. The RNA pellets were air dried at room
temperature and dissolved in sterile DEPC-treated H2O. RNA
concentrations were determined by measuring the optical den-
sity at 260 nm. The two complementary RNA strands were
annealed at an equimolar ratio and dissolved in DEPC-treated
water finally to obtain the siRNA at a concentration of 20 mM.
The integrity and size of the siRNA were assayed by poly-
acrylamide gel electrophoresis under denaturing conditions.
HEK293 cells were transfected with siRNA using the Trans-
Messenger Kit from Qiagen, following the manufacturer’s
instructions. Typically, for a 35 mm Nunc dish, 3.4 ml of
Enhancer-R, 6 ml of siRNA (20 mM) and 8.5 ml of Trans-
Messenger were used. The medium was changed 4 h after
transfection. Control experiments based on non-eRF1 targeting
siRNA were carried out using the same transfection protocol
and the commercially available negative control siRNA from
Qiagen.
Generation of the stable cell line HEK-seRF1
Complementary DNA nucleotides were annealed and ligated
into pSIREN-RetroQ (Clontech), as shown in Figure 1B, giv-
ing rise to the plasmid pSIRENeRF1. This vector leads to the
expression of hairpin RNAs containing a nine-nucleotides
loop, as described by Yu et al. (2002). After calcium phosphate
transfection of HEK293 cells (Jordan et al., 1996), the expres-
sion was maintained by supplementing 1 mg/ml of puromycin
in the growth medium. This selection was made during 3 weeks
prior to real-time PCR experiments.
In vitro transcription of reporter genes
The coding sequence of the red fluorescent protein
DsRedExpress (pDsRedExpress, Clontech) was modified by
the addition of a T7 promoter site and a poly(A) tail using
PCR amplification with synthetic oligonucleotides. The result-
ing fragment was ligated into the pCR2.1 vector using a TA
cloning kit (Invitrogen, Carlsbad, CA) to obtain the plasmid
pT7PDsRedExpress, which was analysed by restriction
mapping and DNA sequencing.
Fig. 1. Scheme of the synthesis of interfering RNAs targeting the eRF1 transcripts. (A) siRNA obtained by annealing of complementary, in vitro-transcribed RNA
strands. (B)Hairpin interferingRNAsynthesized in vivo after transfection of the vector pSIRENeRF1.This vectorwas obtainedby annealing and ligating two synthetic
oligonucleotides in the vector pSIREN-RetroQ.
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We used the plasmid pT7PEGFPam64L, described else-
where (Ilegems et al., 2002), as the second template. It contains
the coding sequence of the EGFP (Clontech) with an amber
mutation at an amino acid sequence position important for the
correct folding of the fluorophore.
After linearization of the plasmids pT7DsRedExpress and
pT7EGFPam64L by NotI, in vitro transcription was performed
with T7 RNA polymerase using the MEGAscript kit. Capping
of mRNA was achieved during transcription by replacing 80%
of the GTP level with the cap analog m7G(50)ppp(50)G. After
removing the DNA template by DNase I treatment, the result-
ing mRNAs were purified by successive phenol–chloroform–
isoamyl alcohol (25:24:1) and chloroform–isoamyl alcohol
(24:1) extractions, precipitation with an equal volume of
isopropanol for 1 h at 20C, followed by centrifugation at
0C and 20 800 g for 15 min. The mRNA pellet was dried and
dissolved in sterile DEPC-treated H2O. The integrity and size
of the mRNAs were analysed by agarose gel electrophoresis
under denaturing conditions and the concentration was deter-
mined by measuring the optical density at 260 nm.
Transcription of suppressor tRNA gene
A 116 bp synthetic DNA template encoding the artificial
human suppressor tRNALeuCUA was prepared by annealing
two oligonucletides containing the tRNA gene flanked by a
T7 promoter (Figure 2). The resulting blunt-end DNA fragment
was ligated into pCR4 vector using a TOPO cloning kit
(Invitrogen). The final plasmid (pHumanLeuCUA) was
checked by restriction mapping and sequencing. This plasmid
was linearized by successive restriction endonuclease digests
with EcoRI and BsaI. After agarose gel purification, this DNA
fragment was used for the run-off transcription with T7 RNA
polymerase following the protocol of the MegaScript Kit. After
removing the template DNA by DNase I treatment, the tRNA
was purified by following the protocol described above for
mRNA. The integrity and purity of the tRNA were assayed
by polyacrylamide gel electrophoresis and the concentration
was determined by measuring the optical density at 260 nm.
cDNA preparation and real-time PCR quantification
Total messenger RNA was extracted from 2 million cells per
sample using TRIZOL Reagent (Invitrogen). The subsequent
eRF1 reverse transcription was achieved using a TaqMan Gold
RT-PCR Kit from Applied Biosystems (Foster City, CA) and
random hexamers. We used the SYBR Green I kit (Eurogentec,
Seraing,Belgium) for quantitativePCR, togetherwith the eRF1-
specific primers 50-TCACAGACAAAGAGACCGGACA-30
and 50-CGCAAGATACCTCCAATTCCAC-30. Primers used
for the internal reference gene glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) were supplied in the TaqMan
Gold RT-PCR Kit (Applied Biosystems). The ABI Prism
7700 was used as a sequence detection system and data
were treated with the software Sequence Detection Systems
1.9.1, both from Applied Biosystems. The amplification
specificities were controlled with dissociation measurements
followed by treatment using Dissociation Curves 1.0 software
(Applied Biosystems). The efficiencies of the reactions were
calculated using LinRegPCR 7.4 (Ramakers et al., 2003), with
a minimum of five data points for the determination of each
amplification slope.
Injections
Microinjections of HEK293 cells with mRNA and tRNA mix-
tures diluted in sterile DEPC-treated water were performed
using an InjectMan controller and a Transjector 5246 system
(both from Eppendorf, Hamburg, Germany) mounted on
an Axiovert S100TV inverted microscope (Carl Zeiss,
Oberkochen, Germany). FemtotipsII capillaries (Eppendorf)
were used for all injections.
Laser scanning confocal microscopy and fluorescence
measurements
Laser scanning confocal microscopy was performed using
a Zeiss LSM510 (Carl Zeiss). Detection and distinction of
the fluorescence signals of EGFP (excitation at 488 nm) and
DsRedExpress (excitation at 543 nm) were achieved by appro-
priate filter sets using a multitracking mode. Scanning speed
and laser intensity were adjusted to avoid photobleaching of
the fluorophores and proper comparison between samples of
variable fluorescence intensities.
Results
A schematic view of our strategy to improve mis-acylated
tRNA suppression efficiency in human cells is presented in
Figure 3. In a first step the intracellular mRNA level of eRF1
is lowered via RNA interference and its effect on nonsense
suppression is later evaluated by microinjection of reporter
mRNAs. One of the transcripts gives rise to the suppression-
dependent expression of a green fluorescent protein. The other
non-mutated, red fluorescent reporter is used as an internal
Fig. 2. Scheme for the in vitro synthesis of the suppressor tRNA from a
synthetic DNA template by T7 run-off transcription. Two synthetic comple-
mentary oligonucleotides encoding the artificial human suppressor tRNALeuCUA
were annealed and cloned into the pCR4 vector, leading to pHumanLeuCUA.
T7 RNA polymerase run-off transcription was performed on the purified EcoRI
and BsaI fragment giving rise to a 87-mer suppressor tRNA.
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standard for the amount of injected molecules, allowing the
comparison between individual cells (Figure 3).
Lowering of the intrinsic eRF1 messenger concentration
has been approached in two different ways using either a
transient siRNA transfection or a stable transcription of a
hairpin RNA, both targeting eRF1 transcripts (Figure 1). The
siRNA sequence was designed following the guidelines
described elsewhere (Elbashir et al., 2001a,b) and the selection
of a specific location on the target eRF1 mRNA was made such
that both synthesized RNA strands begin with a guanine (Donze
and Picard, 2002).
We studied alterations in eRF1mRNA concentration by real-
time PCR, using glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) as an independent reference gene (Figure 4).
Transfection of siRNA had substantial effect on the eRF1
mRNA concentration, which decreased to 40% of its initial
value within 2 days after transfection. The cell line HEK-seRF1
stably expressing the eRF1 targeting hairpin RNA exhibited
60% of the eRF1 mRNA concentration of non-treated cells.
No noticeable difference was observed in the eRF1 mRNA
level between non-transfected cells and cells pre-transfected
with a control (non-eRF1 targeting) siRNA, either 1 or 2 days
after transfection (data not shown). A certain variability was
observed between experiments carried out on different days, as
shown by the relatively large error bars (Figure 4E). However,
the same decrease pattern for each of the eRF1-downregulated
cell batches was always obtained.
To study the correlation between eRF1 concentration and
artificial suppression efficiency, microinjection experiments
were performed 2 days after siRNA transfection, which we
observed resulted in more homogeneous eRF1 silencing
among cells than via DNA transfection, thus permitting precise
cell-to-cell comparisons. We co-injected DsRedExpress
mRNA, human suppressor tRNALeuCUA and EGFPam64L
Fig. 3. General representation of the eRF1 silencing effect on the mis-acylated tRNA suppression efficiency. Upper line: interfering RNAs in the cell—obtained by
either siRNA or pSIRENeRF1 transfection—lead to a lower intracellular concentration of eRF1. Subsequently, a solution containing DsRedExpress mRNA,
suppressor tRNA and EGFPam64L mRNA is micro-injected into the cell. The tRNA is aminoacylated by endogenous AARSs and the expression of EGFP
reflects the suppression efficiency, whereas the DsRedExpress expression level serves as a standard for non-suppressed translation (shown by typical confocal
images taken 20 h after injection). Lower line: control experiment using non-interfering siRNA, having no effect on the eRF1 level. In the confocal image on the right,
the ratio between the EGFP and the DsRedExpress expression levels reflects an increase in the suppression efficiency after silencing of the eRF1.
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mRNA at fixed ratios and controlled volumes of about
0.05 6 0.01 pl (as described by Ilegems et al., 2002). About
20 h later, the expression of both reporter proteins was
monitored by laser-scanning confocal microscopy. Whereas
the DsRed fluorescence intensity was shown to be proportional
to the number of injected molecules, the EGFP fluorescence
intensity mainly depended on the eRF1-dependent suppression
efficiency. Indeed, the mutated EGFPam64L mRNA is only
translated in a full-length fluorescent EGFP when its amber
codon is suppressed by a specific suppressor tRNA charged
with a leucine (for details, see Ilegems et al., 2002).
Plotting the fluorescence intensity of the DsRedExpress
versus that of EGFP revealed that the suppression efficiency
of the siRNA-transfected cells is increased 5-fold compared
with the non-treated HEK293 cells (Figure 5, Table I).
The expression level of the DsRedExpress was controlled
to be independent of the siRNA transfection by co-injecting
treated and non-treated cells with DsRedExpress mRNA
together with purified rEGFP as an indicator for injection
volume: the DsRedExpress expression level was identical
regardless of the eRF1 concentration and depended only on
the injection volume reflected by the rEGFP fluorescence
intensity (data not shown).
Discussion
We developed a strategy to enhance the yield of artificial
nonsense codon suppression in cultured human cells. The
eukaryotic release factor eRF1, which is known to compete
with suppressor tRNAs for stop codon recognition (Drugeon
Fig. 4. Real-time PCR experiments. (A)–(D) PCR profiles of the amplifications of eRF1 andGAPDH (used as an internal standard). The cDNAswere produced from
(A) non-transfected cells or cells transfected with a non-interfering siRNA, (B) cells transfected with siRNA 1 day before, (C) cells transfected with siRNA 2 days
before and (D)HEK-seRF1cells (HEK293 cells stably transfectedwith pSIRENeRF1). Curves are representative of single experiments. (E) Comparison of the level of
eRF1 mRNA in the different samples, using GAPDH as an internal standard. Error bars take into account experimental uncertainty and standard deviations
representative of the values obtained from triplicate experiments carried out on different days.
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et al., 1997), was down-regulated on the transcript level. Based
on the silencing properties of interfering RNA, a substantial
decrease in eRF1 mRNA concentration was achieved. The
silencing effect was followed by real-time PCR and increased
over time to result in a two-fold reduction of eRF1 transcripts
2 days after transfection. A comparable degree of gene silen-
cing was obtained by stable transfection of HEK293 cells with
a vector capable of inducing in vivo transcription of a hairpin
RNA for targeting eRF1 mRNAs.
The effect of eRF1 gene silencing on nonsense codon
suppression efficiency was investigated in individual cells
by co-injection of an artificial suppressor tRNA together
with in vitro transcripts encoding two reporter proteins,
DsRedExpress and EGFPam64L. The suppressor tRNA was
designed in order to obtain a natural aminoacylation by human
cells, required for charging it with a leucine to recover the
green fluorescence of the EGFPam64 reporter by amber
codon suppression. The tRNA sequence used in this study
was based on the human tRNALeuCAA (Breitschopf et al.,
1995), which anticodon was mutated to CUA and which
was modified by two other mutations A38G/A39 U to improve
amber suppression efficiency (Raftery and Yarus, 1987).
Only by co-injecting the amber codon containing EGFP
transcript together with the cognate suppressor tRNA was
complete translation achieved as indicated by EGFP fluore-
scence recovery. The injection of the EGFPam64L reporter
alone did not result in detectable expression of fluorescent
proteins as judged by laser-scanning confocal microscopy
(see also Ilegems et al., 2002). DsRedExpress mRNA encoding
a red fluorescent protein was co-injected as a standard reflect-
ing the amount of injected molecules. Since the two reporter
mRNAs were always injected at the same molar ratio, the ratio
between the resulting EGFP and the DsRedExpress fluore-
scence intensities could be used to compare suppression
efficiencies in individual cells. Lowering the eRF1 mRNA
concentration by a factor of 2 resulted in a 5-fold increase
in suppression efficiency compared with non-treated HEK293
cells. Parallel to our present research, Carnes et al. reported a
slight enhancement of natural nonsense read-through after 90%
silencing of eRF1 transcripts in human cells (Carnes et al.,
2003). These experiments were done in the absence of artificial
suppressor tRNAs. On the basis of our study, we are now able
to confirm a positive influence of eRF1 silencing also on
artificial nonsense codon suppression.
In general, increased read-through might be problematic
for the specific incorporation of non-natural amino acids when
using cell lines exhibiting a strong natural suppression; in such
a situation, the amount of proteins translated without the
desired synthetic amino acid incorporation would increase rela-
tive to the labeled protein. However, we determined natural
amber codon suppression to be very low in HEK293 cells (see
Supplementary data available at PEDS Online), making them
well suited for labeling experiments. By silencing eRF1 tran-
scripts down to 40% of the original level, we could achieve
increased artificial amber suppression without enhancing nat-
ural read-through.
In our hands, further silencing of eRF1 by using the strong
interfering RNA si1187 (Carnes et al., 2003) led to changes in
cell morphology as indicated by their detachment from the
growth surface, thus impairing microinjection experiments
and subsequent subcellular investigations by fluorescence
confocal microscopy (not shown).
The prospects for suppression of nonsense codons in pro-
karyotes and also in eukaryotes might be influenced by the
same strategy involving the downregulation or deactivation
of intrinsic translation termination factors. This was demon-
strated in previous in vitro experiments by Hecht’s group
(Short et al., 1999): partial heat deactivation of a thermo-
sensitive mutant of the prokaryotic release factor 1 (RF1)
increased amber codon suppression by chemically misacylated
suppressor tRNAs in cell-free E.coli extracts using dehydro-
pholate reductase (DHFR) as a reporter protein.
Our present approach based on siRNA could be a valuable
tool, potentially adaptable to various cell types owing to the
generality of the interfering RNA mechanism. Moreover,
Fig. 5. Fluorescence intensities of DsRedExpress and EGFP 20 h after
co-injection of DsRedExpress mRNA, suppressor tRNA and EGFPam64L
mRNA, as measured by confocal microscopy. Each data point represents a
single cell (squares represent non-treated cells, triangles represent cells pre-
transfected with siRNA targeting the eRF1). The discontinuous lines display
qualitatively the validity of the DsRed reporter protein for proper cell-to-cell
comparison, by their apparent linearity in the particular injection volume range
used for this study.
Table I. Concentration of eRF1 mRNA as determined by real-time PCR,
and its effect on mis-acylated suppression efficiency as deduced from
DsRedExpress/EGFP expression level ratios
Intracellular
eRF1 mRNA
concentration
Mis-acylated
tRNA suppression
efficiency
Non-treated HEK293 cells 100% 100%
HEK transfected with siRNA:
1 day after transfection
83 6 70% ND
HEK transfected with siRNA:
2 days after transfection
39 6 33% 500 6 100%
HEK-seRF1 cells 57 6 60% ND
All samplesweremicroinjected using concentrations of 2mg/ml DsRedExpress
mRNA, 2 mg/ml EGFPam64L mRNA, 2 mg/ml tRNA, and imaged 20 h later.
Suppression efficiency was determined by averaging the ratio EGFP/DsRed
fluorescence intensity in single injected cells. The error bars represent
experimental uncertainty as well as standard deviations between individual
experiments. All values are normalized to non-treated HEK293 cells.
ND, not determined.
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although we used microinjection in this present study for quan-
tification reasons, this improvement strategy could be benefi-
cial using other transfection techniques such as electroporation.
Finally, our system could also serve for the site-specific incor-
poration of a wide variety of non-natural amino acids
To conclude, we have provided a general approach for
increasing the efficiency of non-natural amino acid mutagen-
esis since eRF1 is the sole release factor in eukaryotic cells
catalysing translation termination at all three stop codons. A
homogeneous down-regulation of eRF1 transcripts was
achieved in populations of HEK293 cells by transient
siRNA transfection, which resulted in similar levels of elevated
artificial nonsense suppression in individual cells. This is a
significant advance because human cells are most suited for
the analysis of proteins of medical importance.
In addition, we have been able to measure low levels of
natural amber codon suppression in HEK293 cells (see Sup-
plementary data). This is a key advantage of that cell type since
a competition between exogenously added artificial suppressor
tRNAs and high levels of natural suppressor tRNAs, which
might occur in other cell lines, would impair the desired incor-
poration of non-natural amino acid at amber codon sites. Stable
or transient engineering of mammalian cells to achieve desired
biological properties, as presented in our study, is a promising
approach to expand the scope of the in vivo nonsense suppres-
sion methodology.
Our present report on the improvement of the site-selective
incorporation of non-natural amino acids makes this method of
special interest for the in vivo labeling of proteins. Together
with complementary orthogonal labeling methods such as
FLASH (Adams et al., 2002), oligohistidine-NTA chromo-
phores (Guignet et al., 2004) or the human alkylguanine trans-
ferase procedure (Keppler et al., 2003), this approach will offer
many applications to investigate selective molecular interac-
tions allowing the elucidation of structure–function relation-
ships in live biological cells.
Acknowledgement
This work was financially supported by the TopNano 21 programme (CTI
project No. 6266.1 TNS).
References
Adams,S.R., Campbell,R.E., Gross,L.A., Martin,B.R., Walkup,G.K., Yao,Y.,
Llopis,J. and Tsien,R.Y. (2002) J. Am. Chem. Soc., 124, 6063–6076.
Beene,D.L., Brandt,G.S., Zhong,W., Zacharias,N.M., Lester,H.A. and
Dougherty,D.A. (2002) Biochemistry, 41, 10262–10269.
Bertram,G., Bell,H.A., Ritchie,D.W., Fullerton,G. andStansfield,I. (2000)RNA,
6, 1236–1247.
Bertram,G., Innes,S., Minella,O., Richardson,J. and Stansfield,I. (2001)
Microbiology, 147, 255–269.
Breitschopf,K., Achsel,T., Busch,K. and Gross,H.J. (1995) Nucleic Acids Res,
23, 3633–3637.
Carnes,J., Frolova,L., Zinnen,S., Drugeon,G., Phillippe,M., Justesen,J.,
Haenni,A.L., Leinwand,L., Kisselev,L.L. and Yarus,M. (2000) RNA, 6,
1468–1479.
Carnes,J., Jacobson,M., Leinwand,L. and Yarus,M. (2003) RNA, 9, 648–653.
Chiu,Y.L. and Rana,T.M. (2002) Mol. Cell, 10, 549–561.
Chollet,A., Turcatti,G., Nemeth,K. and Vogel,H. (1998) In Slavik,J. (ed.),
Fluorescence Microscopy and Fluorescent Probes, Vol. 2. Plenum Press,
New York, pp. 87–92.
Cload,S.T., Liu,D.R., Froland,W.A. and Schultz,P.G. (1996) Chem. Biol., 3,
1033–1038.
Cohen,B.E., McAnaney,T.B., Park,E.S., Jan,Y.N., Boxer,S.G. and Jan,L.Y.
(2002) Science, 296, 1700–1703.
Czaplinski,K., Ruiz-Echevarria,M.J., Paushkin,S.V., Han,X., Weng,Y.,
Perlick,H.A., Dietz,H.C., Ter-Avanesyan,M.D. and Peltz,S.W. (1998)
Genes Dev., 12, 1665–1677.
Donze,O. and Picard,D. (2002) Nucleic Acids Res., 30, e46.
Drugeon,G., Jean-Jean,O., Frolova,L., Le Goff,X., Philippe,M., Kisselev,L. and
Haenni,A.L. (1997) Nucleic Acids Res., 25, 2254–2258.
Elbashir,S.M., Harborth,J., Lendeckel,W., Yalcin,A., Weber,K. and Tuschl,T.
(2001a) Nature, 411, 494–498.
Elbashir,S.M., Lendeckel,W. and Tuschl,T. (2001b) Genes Dev., 15, 188–200.
Guignet,E.G., Hovius,R. and Vogel,H. (2004) Nat. Biotechnol., 22, 440–444.
Hilleren,P. and Parker,R. (1999) Annu. Rev. Genet., 33, 229–260.
Hohsaka,T., Kajihara,D., Ashizuka,Y., Murakami,H. and Sisido,M. (1998)
J. Am. Chem. Soc., 121, 34–40.
Ilegems,E., Pick,H.M. and Vogel,H. (2002) Nucleic Acids Res., 30, e128.
Jordan,M., Schallhorn,A. and Wurm,F.M. (1996) Nucleic Acids Res., 24,
596–601.
Karginov,V.A., Mamaev,S.V. and Hecht,S.M. (1997) Nucleic Acids Res., 25,
3912–3916.
Keppler,A., Gendreizig,S., Gronemeyer,T., Pick,H., Vogel,H. and Johnsson,K.
(2003) Nat. Biotechnol., 21, 86–89.
Kurzchalia,T.V., Wiedmann,M., Breter,H., Zimmermann,W., Bauschke,E.
and Rapoport,T.A. (1988) Eur. J. Biochem., 172, 663–668.
Le Goff,X., Philippe,M. and Jean-Jean,O. (1997) Mol. Cell. Biol., 17,
3164–3172.
Liu,D.R. and Schultz,P.G. (1999) Proc. Natl Acad. Sci. USA, 96, 4780–4785.
Liu,D.R., Magliery,T.J., Pastrnak,M. and Schultz,P.G. (1997) Proc. Natl Acad.
Sci. USA, 94, 10092–10097.
McManus,M.T. and Sharp,P.A. (2002) Nat. Rev. Genet., 3, 737–747.
Milligan,J.F.,Groebe,D.R.,Witherell,G.W. andUhlenbeck,O.C. (1987)Nucleic
Acids Res., 15, 8783–8798.
Monahan,S.L., Lester,H.A. and Dougherty,D.A. (2003) Chem. Biol., 10,
573–580.
Noren,C.J., Anthony-Cahill,S.J., Suich,D.J., Noren,K.A., Griffith,M.C. and
Schultz,P.G. (1990) Nucleic Acids Res., 18, 83–88.
Raftery,L.A. and Yarus,M. (1987) EMBO J., 6, 1499–1506.
Ramakers,C., Ruijter,J.M., Deprez,R.H. and Moorman,A.F. (2003) Neurosci.
Lett., 339, 62–66.
Short,G.F., 3rd, Golovine,S.Y. and Hecht,S.M. (1999) Biochemistry, 38,
8808–8819.
Strømgaard,A., Jensen,A.A. and Strømgaard,K. (2004) Chembiochem, 5,
909–916.
Turcatti,G., Nemeth,K., Edgerton,M.D., Meseth,U., Talabot,F., Peitsch,M.,
Knowles,J., Vogel,H. and Chollet,A. (1996) J. Biol. Chem., 271,
19991–19998.
Turcatti,G., Nemeth,K., Edgerton,M.D., Knowles,J., Vogel,H. and Chollet,A.
(1997) Receptors Channels, 5, 201–207.
Wang,L., Brock,A., Herberich,B. and Schultz,P.G. (2001) Science, 292,
498–500.
Wang,L., Brock,A. and Schultz,P.G. (2002) J. Am.Chem. Soc., 124, 1836–1837.
Yu,J.Y., DeRuiter,S.L. and Turner,D.L. (2002) Proc. Natl Acad. Sci. USA, 99,
6047–6052.
Received August 9, 2004; revised November 30, 2004;
accepted December 15, 2004
Edited by Thomas Kiefhaber
eRF1 silencing increases artificial suppression
827
